Chorioretinitis is inflammation that affects both the choroid (the blood-vessel-rich layer behind the retina) and the retina itself, and it can threaten vision if left untreated. The condition arises from a surprisingly wide range of causes, from parasitic infections to autoimmune disorders, and the specific culprit shapes everything from the pattern of lesions an eye doctor sees to the treatment a patient receives. Because the choroid is responsible for nourishing the outer retina, inflammation there tends to damage the very tissue it feeds, which is why chorioretinitis carries a real risk of permanent visual loss even after the inflammation subsides.
Infectious Causes and Why Toxoplasma Dominates the List
Among all the organisms that can inflame the choroid and retina, Toxoplasma gondii stands out as the single most common infectious cause worldwide. This parasite, carried by cats and found in undercooked meat, was first linked to human disease in the late 1930s and has been recognized as a major cause of chorioretinitis ever since.1International Journal for Parasitology. Toxoplasmosis: A history of clinical observations In people with healthy immune systems, toxoplasma chorioretinitis typically appears as a single focal area of retinal whitening, often adjacent to an older scar from a previous episode. The classic finding on eye exam is a “headlight in the fog” appearance: a bright, active lesion glowing through a haze of inflammatory cells in the vitreous gel.
When the immune system is compromised, though, toxoplasma chorioretinitis can look very different. In immunocompromised patients, the lesions may be bilateral (affecting both eyes), multifocal, and unusually large, with extensive areas of retinal tissue death that can mimic viral retinitis.2PubMed Central. Active toxoplasma chorioretinitis in immunocompromised patients: a case series This atypical presentation is one reason why diagnosing the condition correctly in people on immunosuppressive therapy or living with HIV can be genuinely difficult.
Cytomegalovirus (CMV) is another major infectious player, particularly in people with advanced HIV. CMV retinitis was one of the hallmark complications of AIDS before modern antiretroviral therapy became widely available, and it remains a concern for anyone with severe immune suppression, including organ transplant recipients and patients on certain chemotherapy regimens.3PubMed. Cytomegalovirus Retinitis: A Review The virus reaches the retina through the bloodstream, and without specific antiviral treatment the infection progresses relentlessly, destroying retinal tissue and causing irreversible blindness.4PubMed Central. Cytomegalovirus Retinitis as a Sole Manifestation of HIV Infection
Syphilis and tuberculosis round out the list of infections that eye specialists keep in mind. Both can produce chorioretinitis with overlapping features, and in parts of the world where these infections are common, they must be considered in anyone presenting with unexplained posterior eye inflammation. Coinfection complicates matters further. One documented case involved a patient with simultaneous HIV, syphilis, and active pulmonary tuberculosis, all contributing to a single chorioretinitis lesion. Polymerase chain reaction testing of fluid drawn from the eye confirmed tuberculosis as the cause of that particular lesion.5PubMed Central. Triple trouble: A case of retinochoroiditis in a patient with syphilis, tuberculosis, and human immunodeficiency virus infection
Parasitic Infections Beyond Toxoplasma
While Toxoplasma gets most of the attention, two other organisms deserve mention because they cause chorioretinal disease through different mechanisms.
Toxocara species (roundworms carried by dogs and cats) can migrate into the eye, especially in children who ingest contaminated soil. Unlike toxoplasma, which causes inflammation by actively replicating inside retinal cells, toxocara larvae physically burrow into ocular tissue and provoke a granulomatous response. Ocular toxocariasis typically affects only one eye and tends to present as a whitish or yellowish inflammatory mass in the back of the eye or the peripheral retina.6PubMed Central. Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention The clinical picture breaks down into three main patterns: chronic endophthalmitis (diffuse inflammation of the entire interior of the eye), a granuloma near the optic nerve, or a granuloma out in the peripheral retina.7PubMed. Ocular toxocariasis: new diagnostic and therapeutic perspectives
Histoplasma capsulatum, a fungus found in soil enriched with bird or bat droppings, causes a condition known as presumed ocular histoplasmosis syndrome. The name includes “presumed” because the organism itself is almost never recovered from the eye. Instead, the diagnosis rests on a characteristic pattern of small, punched-out chorioretinal scars scattered across the retina, along with changes around the optic nerve.8Advances in Ophthalmology & Visual System. Secondary open-angle glaucoma in presumed ocular histoplasmosis syndrome These scars themselves rarely cause symptoms, but they can become the site where abnormal new blood vessels grow later in life, threatening central vision.
When the Immune System Turns on the Eye
Not all chorioretinitis is caused by an infection. A substantial portion of cases stems from autoimmune or inflammatory processes in which the body’s own immune response attacks retinal and choroidal tissue.
Vogt-Koyanagi-Harada syndrome (VKH) is one of the more dramatic examples. This autoimmune condition targets melanocytes, the pigment-producing cells found in the choroid, skin, hair, and inner ear. The eye involvement typically begins in the back of the eye, producing bilateral diffuse chorioretinitis along with fluid buildup that can detach the retina.9PubMed Central. Advances in the Study of the Pathogenesis of Vogt-Koyanagi-Harada Syndrome Patients sometimes also develop skin depigmentation (vitiligo), whitening of the hair or eyelashes, and hearing problems, which together point toward the diagnosis.
Sarcoidosis, a systemic inflammatory disease that forms tiny nodules called granulomas in various organs, can also affect the eye. A study of 48 consecutive patients with a form of peripheral multifocal chorioretinitis found that roughly half had either confirmed or suspected sarcoidosis, while the other half had no identifiable systemic disease at all.10PubMed. Arterial macroaneurysms in peripheral multifocal chorioretinitis associated with sarcoidosis That split illustrates a recurring frustration in this field: even with thorough workup, a meaningful fraction of chorioretinitis cases end up being labeled “idiopathic,” meaning no cause can be identified.
The so-called white dot syndromes are another group of inflammatory chorioretinopathies that can look similar to infectious chorioretinitis on initial examination. These conditions share a hallmark appearance of multiple yellow-white lesions scattered across the retina, the retinal pigment layer, and the choroid, but their underlying cause remains unknown.11PubMed Central. A review of the inflammatory chorioretinopathies: the white dot syndromes Distinguishing them from infection matters enormously, because immunosuppressive drugs that help autoimmune chorioretinitis could worsen an unrecognized infection.
What Patients Actually Notice
Chorioretinitis does not always announce itself with obvious pain. The choroid and retina lack the type of sensory nerve endings that produce sharp pain signals, so the inflammation can be quite advanced before a patient realizes something is wrong. The most common early symptoms are floaters (drifting spots or webs in the visual field caused by inflammatory cells in the vitreous), blurred vision, and photopsia (flashes of light). Over time, night blindness and changes in color perception can develop.
A study of 11 patients with vitiliginous chorioretinitis, a depigmenting form of the condition, documented this typical symptom arc: onset of floaters and light flashes in otherwise healthy adults, followed by blurred vision and later by night blindness and color vision deficits. The condition tended to stabilize over time, and most patients retained good central vision in at least one eye, though some degree of damage accumulated.12JAMA Network. Vitiliginous Chorioretinitis This natural history of gradual stabilization does not apply to all forms of chorioretinitis, however. Toxoplasma and CMV-driven cases can flare repeatedly, and each recurrence risks additional retinal destruction.
Location matters enormously. A small lesion in the peripheral retina might go completely unnoticed, while a lesion of the same size at or near the macula (the central area responsible for sharp, detailed vision) can cause significant visual impairment. This is one reason why two patients with the “same” diagnosis can have wildly different experiences.
Congenital Chorioretinitis in Newborns and Infants
When chorioretinitis is present at birth or develops shortly after, the two infections most commonly responsible are Toxoplasma and CMV. Both can cross the placenta during pregnancy and infect the developing fetus, but they tend to behave differently in the eye.
Congenital toxoplasmosis is particularly prone to causing chorioretinitis. In one early study tracking infected children, nine out of twelve born with congenital toxoplasmosis had eye pathology. Strikingly, chorioretinitis developed after birth in five of eight patients who had been born with no obvious symptoms of their infection, underscoring the importance of long-term follow-up even in apparently healthy exposed newborns.13Pediatrics. Auditory and Visual Defects Resulting from Symptomatic and Subclinical Congenital Cytomegaloviral and Toxoplasma Infections
Congenital CMV infection affects the eye differently from the adult form of CMV retinitis. In adults, CMV tends to produce focal changes in the peripheral retina. In congenital infection, the macula is more likely to be involved, and the degree of visual impairment tracks directly with how much scarring develops in the central retina.14PubMed. Recurrent Congenital Cytomegalovirus Chorioretinitis in a Newborn. A Case Report Animal research using mice infected with murine CMV shortly after birth has confirmed that the infection recapitulates key features of human congenital CMV eye disease, including focal chorioretinitis, inflamed blood vessels, and breakdown of the blood-retinal barriers that normally protect the retina.15PubMed Central. Immune responses drive chorioretinitis and retinal pathology after neonatal CMV infection That same research found that the immune response itself, not just the virus, drives much of the retinal damage, which has implications for how aggressively clinicians might one day manage the inflammatory component alongside antiviral therapy.
How Chorioretinitis Is Diagnosed
The first step is a thorough dilated eye exam. An ophthalmologist uses indirect ophthalmoscopy and slit-lamp biomicroscopy to look at the retina and choroid, assessing the number, size, location, and activity of any lesions. Active lesions tend to appear whitish or yellowish with indistinct borders, often with overlying vitreous haze, whereas inactive scars are sharply demarcated with pigment clumping at their edges.
Optical coherence tomography (OCT) has become indispensable for evaluating chorioretinitis. This noninvasive imaging technique generates cross-sectional views of the retina and choroid at near-microscopic resolution. In active chorioretinitis, OCT typically reveals areas of increased reflectivity extending through the full thickness of the retina at the site of the lesion.16PubMed. Combined en-face optical coherence tomography and confocal ophthalmoscopy findings in active multifocal and serpiginous chorioretinitis OCT can also detect subtle features that distinguish one type of chorioretinitis from another. In conditions like multifocal choroiditis and punctate inner choroidopathy, for instance, disruption of a specific layer called Bruch’s membrane has been found in the vast majority of lesions, a feature that helps set these apart from other inflammatory lesions.17American Journal of Ophthalmology. Optical Coherence Tomography Features of Inactive Multifocal Choroiditis With Panuveitis and Punctate Inner Choroidopathy Lesions
Beyond imaging, blood tests help narrow down the underlying cause. A typical workup includes serology for toxoplasma, syphilis, and HIV; a tuberculin skin test or interferon-gamma release assay; chest imaging looking for sarcoidosis or tuberculosis; and sometimes testing for less common infections like bartonella or herpes viruses. When the clinical picture is ambiguous, fluid can be drawn from the front chamber of the eye (aqueous tap) and tested using polymerase chain reaction to detect microbial DNA directly.
Complications That Outlast the Inflammation
Even after chorioretinitis is successfully treated and the inflammation subsides, the damage it leaves behind can create new problems years later. The most feared late complication is choroidal neovascularization (CNV), in which abnormal new blood vessels grow from the choroid through breaks in the tissue left by scarring. These fragile new vessels leak fluid and blood under the retina, causing sudden and sometimes severe vision loss.
CNV was recognized as a late complication of toxoplasma scars decades ago. In a classic report, three patients with quiescent chorioretinal scars presumed to be from toxoplasmosis developed choroidal neovascular membranes that caused abrupt drops in visual acuity.18PubMed. Choroidal neovascularization as a late complication of ocular toxoplasmosis The same complication has been documented with syphilitic chorioretinitis, where bilateral CNV was confirmed using OCT angiography in a patient whose initial infection had been treated and was no longer active.19PubMed. Choroidal neovascularization as a late complication of syphilitic chorioretinitis managed with intravitreal aflibercept The practical takeaway is that patients with a history of chorioretinitis need ongoing monitoring even after the active disease resolves, because CNV can emerge months or years later and is treatable with anti-VEGF injections if caught early enough.
Other complications include epiretinal membrane formation (a sheet of scar tissue growing across the surface of the retina), cystoid macular edema (fluid-filled cysts in the central retina), retinal detachment from traction by scar tissue or from chronic fluid accumulation, cataract formation (especially if corticosteroids are used long-term), and glaucoma from chronic inflammation or steroid use.
Treatment Depends Entirely on the Cause
There is no one-size-fits-all treatment for chorioretinitis because the correct approach hinges on whether an infection is present and, if so, which one. Getting the etiology wrong can be dangerous: giving immunosuppressive drugs for what turns out to be an infection can allow it to spread, while withholding them for an autoimmune condition lets the immune-mediated damage continue unchecked.
For toxoplasma chorioretinitis, the standard approach combines antiparasitic drugs with corticosteroids to reduce the collateral damage from inflammation. Traditional regimens use a combination of pyrimethamine, sulfadiazine, and a corticosteroid. Research into more aggressive regimens has shown some promise: a study comparing quadruple-drug therapy (adding a fourth antimicrobial agent) to triple-drug therapy found significantly faster initial lesion shrinkage with the four-drug combination, though by the final follow-up visit the overall degree of healing was similar between groups.20PubMed Central. Rapid resolution of toxoplasma chorioretinitis treatment using quadruple therapy Speed of resolution matters because less time spent actively inflamed generally means less scarring.
CMV retinitis requires systemic or intravitreal antiviral therapy, typically with ganciclovir or valganciclovir. In patients with HIV, restoring immune function with antiretroviral therapy is the single most important intervention, because without a functioning immune system the virus will reactivate repeatedly.
For noninfectious chorioretinitis, treatment centers on suppressing the immune response. Corticosteroids are the first-line agents, delivered as eye drops for mild anterior involvement or as oral pills, injections around the eye, or intravitreal implants for more severe posterior disease. When steroids alone are insufficient or when long-term steroid side effects become a concern, immunosuppressive medications or biologic agents may be added.21PubMed Central. A Review of Systemic Biologics and Local Immunosuppressive Medications in Uveitis
Why Chorioretinitis Gets Misdiagnosed
Misdiagnosis is a genuine problem in this space, and it happens for understandable reasons. Many of the infectious and noninfectious forms of chorioretinitis produce lesions that look remarkably similar on clinical examination, especially early in their course. A toxoplasma lesion can mimic a white dot syndrome. Syphilitic chorioretinitis can imitate almost anything. CMV retinitis in its early stages can look like progressive outer retinal necrosis caused by varicella-zoster virus.
The consequences of a wrong call can be serious. An infectious lesion misidentified as autoimmune may be treated with steroids alone, which temporarily reduces inflammation but allows the organism to proliferate unchecked. Conversely, a noninfectious case treated empirically with antibiotics delays the immunosuppression that would actually help. This diagnostic challenge is compounded in patients with weakened immune systems, where atypical presentations are the norm rather than the exception. In such patients, toxoplasma chorioretinitis can present without the adjacent old scar that usually tips off the clinician, and the widespread necrosis can closely resemble viral retinitis.22PubMed Central. Active toxoplasma chorioretinitis in immunocompromised patients: a case series
The push toward better diagnostic imaging and more routine use of aqueous or vitreous sampling for PCR testing aims to close this gap. In practice, though, many cases are still diagnosed based on clinical appearance, patient demographics, and serological testing, with a definitive microbiological answer remaining elusive in a frustrating number of patients.
Living with Recurrent Disease
For many patients, chorioretinitis is not a one-time event but a recurring condition. Toxoplasma chorioretinitis is especially notorious for recurrences, which can happen months or years after the initial episode. Each recurrence tends to occur at the border of a previous scar, gradually enlarging the area of damaged retina. Over years and multiple episodes, this progressive scarring can encroach on the macula and threaten central vision even if the original lesion was safely peripheral.
Whether long-term preventive antibiotic therapy can reduce recurrence rates in toxoplasma chorioretinitis remains an active area of research. Some clinicians prescribe intermittent courses of trimethoprim-sulfamethoxazole for patients with frequent relapses, though the evidence base for this practice is still being built. The decision usually weighs the frequency and severity of past episodes against the side effects of prolonged antibiotic use.
Patients with noninfectious chorioretinitis face their own version of the recurrence problem. Autoimmune conditions like VKH can flare when immunosuppression is tapered too quickly, and the white dot syndromes have variable natural histories: some resolve entirely on their own, while others smolder chronically. Regular follow-up with an ophthalmologist who specializes in uveitis and retinal inflammatory disease is the most practical thing a patient can do. OCT imaging at each visit allows detection of subclinical activity or early CNV, and catching these problems before symptoms develop gives treatment the best chance of preserving vision.